-
公开(公告)号:US10478527B2
公开(公告)日:2019-11-19
申请号:US15757475
申请日:2016-09-05
Inventor: Viness Pillay , Yahya Essop Choonara , Pradeep Kumar , Lisa Claire Du Toit , Poornima Ramburrun
Abstract: This invention relates to biodegradable implants comprising a hydrogel carrier matrix having dispersed therein a multitude of particles, wherein each of the multitude of particles and/or the hydrogel carrier matrix includes an active pharmaceutical ingredient (API) for the treatment of transected peripheral nerve injuries. Each of the multitude of particles and/or the hydrogel carrier matrix includes pristine polymer particles, preferably the pristine polymer particles may be polymethylmethacrylate polymers and derivatives thereof, preferably poly(methacrylic-co-methyl methacrylate) (PMMA). The spheroidal particles may each be formed from an outer shell including a chitosan (CHT) poly(methacrylic-co-methyl methacrylate) (PMMA) polyelectrolyte complex (CHT-PMMA-PEC) and an inner core including crosslinked chitosan having dispersed therein PMMA nanoparticles.
-
公开(公告)号:US20190330276A1
公开(公告)日:2019-10-31
申请号:US16213885
申请日:2018-12-07
Applicant: Symic IP, LLC
Inventor: Alyssa Panitch , Jonathan C. Bernhard , John Eric Paderi , Shaili Sharma
IPC: C07K9/00 , A61L27/36 , C08B37/00 , A61L27/54 , A61L27/48 , C07K14/47 , C08B37/08 , A61K38/39 , A61K38/17 , C07K14/78
Abstract: This invention pertains to the field of hyaluronic acid-binding synthetic peptidoglycans and methods of forming and using the same.
-
公开(公告)号:US10449270B2
公开(公告)日:2019-10-22
申请号:US15443003
申请日:2017-02-27
Applicant: Young Min Ju , Francis Moussy , Thomas J. Koob
Inventor: Young Min Ju , Francis Moussy , Thomas J. Koob
IPC: A61L27/24 , C07K14/78 , A61L27/48 , A61L27/34 , A61L31/04 , A61L31/10 , A61L27/54 , A61L31/12 , A61B5/145 , A61B5/1486 , A61L27/18 , A61L27/56
Abstract: The subject invention concerns non-degradable three dimensional porous collagen scaffolds and coatings. These scaffolds can be prepared around sensors for implantation into a body. A specific embodiment of the invention concerns implantable glucose sensors. Sensors comprising a collagen scaffold of the invention have improved biocompatibility by minimizing tissue reactions while stimulating angiogenesis. The subject invention also concerns methods for preparing collagen scaffolds of the invention. The subject invention also concerns sensors that have a collagen scaffold of the invention around the exterior of the sensor.
-
公开(公告)号:US10441678B2
公开(公告)日:2019-10-15
申请号:US15963337
申请日:2018-04-26
Applicant: Sofradim Production
Inventor: Sébastien Ladet , Julien Claret
IPC: A61L27/20 , A61K9/00 , A61K47/36 , A61L27/56 , A61K45/00 , B05D5/00 , B32B37/24 , A61L27/24 , A61L27/48 , A61L27/54 , A61L27/58
Abstract: Mono- and multi-layered implants include at least one porous layer made from a freeze dried aqueous solution containing chitosan, the solution having a pH of less than about 5.
-
65.
公开(公告)号:US10434216B2
公开(公告)日:2019-10-08
申请号:US15505054
申请日:2015-07-10
Inventor: Gil Son Khang , Eun Young Kim , Jae Won Yang , Jeong Eun Song , Se Rom Cha
Abstract: The present invention relates to an ultra-thin film silk fibroin/collagen composite implant for tissue engineering and a manufacturing method therefor. The ultra-thin film silk fibroin/collagen silk fibroin/collagen composite implant according to the present invention has no cytotoxicity and can minimize the influence on cell growth, due to the combined use of a refined silk fibroin aqueous solution, collagen and various biomaterials, and thus can be widely used as an ultra-thin film implant for implanting.
-
公开(公告)号:US10406261B2
公开(公告)日:2019-09-10
申请号:US14854504
申请日:2015-09-15
Inventor: Nathan J. Castro , Christopher M. O'Brien , Lijie Grace Zhang
IPC: A61L27/48 , A61L27/58 , A61L27/54 , A61L27/12 , A61L27/18 , B33Y10/00 , B33Y70/00 , B33Y80/00 , B29K67/00 , B29K71/00 , B29C64/112
Abstract: The invention describes methods for producing a biphasic nanocomposite scaffold comprising custom polymer-based core-shelled nanospheres by the physical and chemical attachment of two disparate polymeric materials whose composition can be readily modified with tissue-specific nanomaterials and products created using such methods. The custom nanospheres are constructed via co-axial wet electrospraying and can be employed to deliver compounds to the polymeric materials.
-
公开(公告)号:US20190231934A1
公开(公告)日:2019-08-01
申请号:US16361907
申请日:2019-03-22
Applicant: SpineOvations, Inc.
Inventor: Stuart Young , Neville Alleyne , Nicholas John Manesis
Abstract: A method of treating a spinal disk according to the present invention can include inserting an alloplastic bulking agent into the spinal disk to treat the defect. The alloplastic bulking agent has a plurality of microparticles and a suspending agent comprising hyaluronic acid. The bulking agent results in at least one of sealing the defect, increasing a pressure of the disk, increasing a height of the disk, improving stability of the disk and improving structural integrity of the disk.
-
公开(公告)号:US20190216988A1
公开(公告)日:2019-07-18
申请号:US16362246
申请日:2019-03-22
Applicant: Revotek Co., Ltd
Inventor: Yujian James KANG , Xiao ZUO
IPC: A61L31/16 , B28B1/00 , B33Y30/00 , A61L27/44 , A61L27/20 , A61L27/22 , A61L27/38 , B33Y10/00 , C09D11/04 , A61L31/04 , C09D11/03 , A61L27/50 , A61L27/48
CPC classification number: A61L31/16 , A61B2017/00004 , A61B2017/00526 , A61B2017/00893 , A61F2240/001 , A61F2250/0067 , A61L27/20 , A61L27/222 , A61L27/38 , A61L27/3808 , A61L27/3826 , A61L27/3834 , A61L27/44 , A61L27/48 , A61L27/50 , A61L31/047 , A61L2400/06 , B28B1/001 , B33Y10/00 , B33Y30/00 , B33Y70/00 , C09D11/03 , C09D11/04 , C08L5/04
Abstract: A bio-ink composition comprises a plurality of bio-block, in which the bio-blocks can serve as basic building blocks in cell-based bioprinting. The bio-blocks, pharmaceutical compositions comprising the bio-blocks, methods of preparing artificial tissues, tissue progenitors, or multi-dimensional constructs, and methods of preparing the bio-blocks are also provided. The bio-blocks, and the multi-dimensional constructs, artificial tissues, and tissue progenitors comprising the bio-blocks or prepared by the methods described herein are useful for tissue engineering, in vitro research, stem cell differentiation, in vivo research, drug screening, drug discovery, tissue regeneration, and regenerative medicine.
-
公开(公告)号:US20190216979A1
公开(公告)日:2019-07-18
申请号:US16331454
申请日:2017-09-25
CPC classification number: A61L27/446 , A61L27/042 , A61L27/48 , A61L27/52 , A61L2400/06
Abstract: The present invention relates to a macroscopically alignable, injectable, soft hydrogel composition which is able to form an anisotropic structure in vivo, after injection, to generate healthy functioning tissue and regenerate injured or diseased soft tissue.
-
公开(公告)号:US10328179B2
公开(公告)日:2019-06-25
申请号:US14661712
申请日:2015-03-18
Applicant: WARSAW ORTHOPEDIC, INC.
Inventor: Keyvan Behnam , David Knaack
IPC: A61L27/36 , A61K35/32 , A61K38/01 , A61K38/18 , A61L27/12 , A61L27/42 , A61L27/48 , A61L27/54 , C07K14/51 , A61F2/28 , A61F2/30
Abstract: An osteoinductive composition, corresponding osteoimplants, and methods for making the osteoinductive composition are disclosed. The osteoinductive composition comprises osteoinductive factors, such as may be extracted from demineralized bone, and a carrier. The osteoinductive composition is prepared by providing demineralized bone, extracting osteoinductive factors from the demineralized bone, and adding the extracted osteoinductive factors to a carrier. Further additives such as bioactive agents may be added to the osteoinductive composition. The carrier and osteoinductive factors may form an osteogenic osteoimplant. The osteoimplant, when implanted in a mammalian body, can induce at the locus of the implant the full developmental cascade of endochondral bone formation including vascularization, mineralization, and bone marrow differentiation. Also, in some embodiments, the osteoinductive composition can be used as a delivery device to administer bioactive agents.
-
-
-
-
-
-
-
-
-